Spiroxatrine
From Wikipedia, the free encyclopedia
| Spiroxatrine | |
|---|---|
 | |
| IUPAC name 8-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one | |
| Identifiers | |
| CAS number | 1054-88-2  |
| PubChem | 5268 |
| ChemSpider | 5078  |
| MeSH | Spiroxatrine |
| ChEMBL | CHEMBL300555 |
| IUPHAR ligand | 53 |
| Jmol-3D images | Image 1 |
| |
| |
| Properties | |
| Molecular formula | C22H25N3O3 |
| Molar mass | 379.45 g mol−1 |
| (verify) (what is: /?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa) | |
| Infobox references | |
Spiroxatrine is a drug which acts as a selective antagonist at both the 5-HT1A receptor and the α2C adrenergic receptor. It is an analogue of spiperone, and also has some dopamine antagonist effects.
References
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.